Simultaneous assessment of ethanol and acetaldehyde concentrations is necessary to address hypotheses in alcohol research. Accurate measurement of in vivo acetaldehyde following ethanol exposure is problematic because acetaldehyde is present in blank blood, is volatile, and is formed enzymatically and nonenzymatically in blood containing ethanol. Because acetaldehyde is carried in red blood cells, previously reported plasma methods may not reflect total body acetaldehyde. We developed an accurate, sensitive, automated gas chromatographic whole blood method using headspace injection and flame ionization detection. Sensitivity was 5.4 pmol/L and 1.13 pmol/L for ethanol and acetaldehyde, respectively. Linearity (r z > 0.99, both) and reproducibility (coefficients of variation = 1.6-7.7%) were acceptable. Because a whole blood method completely inhibiting in vitro oxidation of ethanol has not been reported, we evaluated multiple reported sample processing methods. The optimum method, which uses saturated sodium nitrite as the inhibitor, resulted in a 30% in vitro increase in acetaldehyde in blood containing 21.7 mmol/L (0.1 g/dL) ethanol, in contrast to the 9-40-folcl increase observed with other inhibitors (p = 0.001). Using the described technique, the median acetaldehyde and ethanol peak concentrations in six African-American women following a 0.5 g/kg oral ethanol dose were 6.1 pM and 17.1mM, respectively.
Introduction
The accurate measurement of acetaldehyde concentrations in blood containing ethanol is difficult as acetaldehyde is formed in vitro both enzymatically and nonenzymatically. In addition, acetaldehyde is volatile and spontaneous and enzymatic oxidation of acetaldehyde occurs rapidly. The choice of method is controversial and is dependent on the needs of a particular investigation and on the degree of accuracy and validity of the assay technique. Currently employed methods use breath analysis (1), high-performance liquid chromatography (HPLC) (2,3), and gas chromatography (4, 5) . Breath acetaldehyde sampling escapes the issue of in vitro formation of acetaldehyde.
However, even with elevated, easily measurable levels of acetaldehyde, breath acetaldehyde concentrations do not correlate with blood concentrations (6) . Breath acetaldehyde may be increased by the formation of acetaldehyde in the mouth, in the airway, or by lung microsomes (7, 8) .
Common HPLC methods require extraction and derivatization techniques that are labor intensive and require the synthesis of several fresh reagents. In addition, the stability of the adducts formed, typically hydrazines (2,9) or cyclohexadiones (10, 11) , has not been reported. Moreover, without immediate deproteinization, derivatized acetaldehyde continues to be formed until the enzymes present in the blood are removed by centrifugation or by deproteinization. Thus, methods that employ derivatization without deproteinization eliminate the loss of acetaldehyde by vaporization and oxidation but cannot eliminate artifactual in vitro formation from ethanol. Two HPLC methods combine deproteinization and adduct formation with fluorescent markers using either methanolic dinitrophenylhydrazine (DNPH) (9, 12) or organic diphenylacetylindandione-hydrazone (DIH) (3,13). The organic portion of these reagents acts as a deproteinizer while the DNPH or DIH forms a fluorescent adduct to acetaldehyde. Another method uses perchloric acid deproteinization and centrifugation followed by derivatization to dinitrophenylhydrazine (14) . These methods are labor intensive and also have the technical problem of a lack of a feasible internal standard. Furthermore, a separate analytical method would be required for ethanol measurement in in vivo studies of ethanol metabolism. Deproteinization of whole blood has been criticized based on the belief that it causes the formation of spurious acetaldehyde by the oxidation of ethanol by red cells (15) . Recognizing that increased oxidation of acetaldehyde and increased in vitro formation of acetaldehyde from ethanol were associated with red blood cells (16, 17) , some investigators preferred to measure plasma acetaldehyde (5, 6, 18, 19) . By quick separation of plasma from red cells, much, but not all, of the in vitro formation of acetaldehyde from ethanol can be eliminated.
A major disadvantage of plasma methods is that the majority of acetaldehyde is circulated in red blood cells (20, 21) . After ethanol exposure, acetaldehyde metabolized from ethanol is converted into Schiff bases bound to lysine and valine residues in proteins (22) . These linkages appear to occur with hemoglobin, red cell membranes (23) , and plasma proteins (24) . This binding tends to occur rapidly after acute ethanol exposure (25) . It is likely that deproteinization releases the more unstable forms of this bound acetaldehyde. Thus, an alternative explanation to spurious acetaldehyde exists for the large increase in acetaldehyde seen with deproteinization techniques. Rather than discrediting whole blood techniques, higher concentrations of acetaldehyde would be anticipated from whole blood measurements than from plasma measurements. Considering the larger quantitative amount of acetaldehyde in red blood cells compared with plasma, total whole blood acetaldehyde rather than the plasma acetaldehyde concentration would seem to better reflect total body acetaldehyde following acute ethanol exposure. Although only free acetaldehyde is thought to cross the blood-brain barrier, free acetaldehyde is rapidly metabolized by aldehyde dehydrogenase. Removal of free acetaldehyde would be expected to lead to the release of loosely bound acetaldehyde. Thus, for exposure purposes, total circulating acetaldehyde would appear more relevant than free acetaldehyde.
The major advantages of gas chromatography methods are the ease of use and the simultaneous measurement of acetaldehyde and ethanol. The sensitivity of newer flame ionization detectors allows adequate acetaldehyde detection for in vivo studies. We developed an accurate, sensitive gas-liquid chromatography assay for simultaneous measurement of ethanol and acetaldehyde using headspace injection and flame ionization detection to study ethanol and acetaldehyde concentrations in human blood following ethanol ingestion. Because complete inhibition of ethanol oxidation has not been achieved with any of the published deproteinization methods, we compared multiple sample processing methods for inhibition of the in vitro oxidation of ethanol and for the relative recovery of acetaldehyde.
Methods

Standards
Stock standards for ethanol (Aaper Alcohol and Chemical, Shelbyville, KY) and acetaldehyde (Aldrich Chemical, Milwaukee, WI) were prepared by dissolving each in doubledistilled water that was freshly boiled and analyzed for possible acetaldehyde contamination. Ethanol, acetaldehyde, and the internal standard, 1-propanol (IS), stock standard solutions were made to concentrations of 2.17 mol/L (10 g/dL), 22.7 mmol/L (100 mg/dL), and 16.6 mmol/L (100 mg/dL), respectively. All standards were prepared in the cold (4~ using cold glassware and pipette tips and were prepared fresh the evening before the run day to vent the cold room of acetaldehyde vapors.
Evaluation of sample processing methods
Compounds selected to test their ability to inhibit the in vitro formation of acetaldehyde from ethanol included saturated sodium nitrite, sodium azide (10raM), polyethylene glycol (20%) with sodium azide (10raM), perchloric acid (0.6N), zinc sulfate (5%) followed by barium hydroxide (0.3N), and semicarbazide (6mM) followed by perchloric acid (3N). The inhibitors and the concentrations selected were chosen based on their reported use by others (5, 15, 26, 27) . Fresh whole blood (6 mL total) was drawn by venipuncture from ten individuals using a butterfly needle and two syringes (5 mL each). No preservatives or anticoagulants were used. For each individual, this whole blood sample was divided into 1-mL aliquots that were placed into ice-cold 10-mL gas chromatography vials. For each inhibitor, two sets of three vials each were prepared. In each set, one vial was a blank control (no analyte added). Ethanol stock solution was added to the whole blood in the second vial of each set to yield a concentration of 21.71JM. Acetaldehyde stock solution was added to the whole blood in the third vial of each set to yield a concentration of 22.71JM. The choice of the concentrations of ethanol and acetaldehyde used were based on concentrations anticipated in clinical studies (16, 28) . To one set of vials, the inhibitor was added within 2 s of the addition of ethanol or acetaldehyde. To the second set, saline was added for volume equivalence. Ten microliters of the internal standard stock solution was added to each vial. After all compounds had been added to the whole blood, the vials were gas-tight sealed and stored at 4~ until analysis. Each sample was assayed for ethanol and acetaldehyde by gas chromatography within 2 h of processing.
In order to compare the in vitro formation of acetaldehyde from ethanol across techniques, we evaluated the increase in acetaldehyde in the presence of ethanol by defining the oxidation inhibition ratio as follows:
AA PAI+ETOH Relative inhibition ratio = AA PA, where AA PAI+ ETOn is the area under the acetaldehyde chromatogram peak in blood containing 21.7 mmol/L ethanol and inhibitor, and AA PAl is the area under the acetaldehyde peak in blood containing inhibitor but no ethanol. Complete inhibition of in vitro ethanol oxidation would generate a ratio of 1.0. We defined the relative recovery of acetaldehyde to compare the impact of the different methods of deproteinization on the recovery of acetaldehyde:
Relative recovery ratio = AA PAI AA PA 0 where AA PA I is the area under the acetaldehyde chromatogram peak in blood containing 22.7 pmol/L acetaldehyde to which the inhibitor was added, and AA PAo is the area under the acetaldehyde peak in blood containing 22.7 pmol/L acetaldehyde and 1 mL saline for volume equivalence, but no inhibitor. Paired t-tests were used to compare the oxidation inhibition and relative recovery ratios of inhibitors. An (~ level less than 0.05 was accepted as statistically significant.
Gas chromatography conditions
Samples were analyzed on a Varian (Sugar Land, TX) 3500 gas chromatograph equipped with a Hewlett Packard (Wilmington, DE) headspace injector. Headspace incubation time was 16 rain at 75~ A 3-mL headspace injection loop was equilibrated with the sample using ultrapure helium (99.999%) at a pressurization of 1.7 bars. Headspace injection time was 30 s and occurred via the Varian split-splitless injector at a helium flow rate of 7.9 mL/min with a measured split ratio of 10. Separation utilized a Carbowax megabore capillary column (Alltech, 30 m, 0.54 ram, 1.2-1Jm film thickness). The makeup gas was nitrogen (99.998%) with a total detector gas flow of 30 mL/min. Detection was by flame ionization (FID) with a 10-fold change in detector range programmed at 2.5 min. Data acquisition used the Varian Star integrator.
Results
The retention times of acetaldehyde, ethanol, and 1-propanol were 1.44, 3.13 and 3.81 rain, respectively ( Figure 1 ). The limits of assay sensitivity were 5.4 iJmol/L and 1.13 IJmol/L for ethanol and acetaldehyde, respectively.
Saturated sodium nitrite was best at preventing the in vitro oxidation of ethanol to acetaldehyde (Table I, p < 0.001, all comparisons). However, the presence of 21.7 mmol/L ethanol increased the amount of acetaldehyde present by 30%. Sodium azide (10raM) was second best, but was much less effective than sodium nitrite (p = 0.001) with an oxidation inhibition ratio indicating more than a ninefold increase in acetaldehyde in blood containing ethanol (Table I) . Perchloric acid, alone and when combined with semicarbazide, and the combination of zinc sulfate with barium hydroxide were much less effective than sodium nitrite or sodium azide at inhibiting in vitro formation, and, in fact, were no better than saline (Table I ). The oxidation inhibition ratios of these three methods indicated an in vitro increase in acetaldehyde of 20-40-fold in the presence of ethanol (Table I) .
In relative recovery of acetaldehyde, sodium nitrite was significantly better than azide with relative recoveries of 3.8 and 2.7, respectively (Table I , p ---0.001). The relative recovery of acetaldehyde was greatest with perchloric acid and with the combination of zinc sulfate and barium hydroxide (Table I) . 
Effect of sodium nitrite concentration
Fresh whole blood from five individuals was drawn into icecold syringes and placed into two sets of ice-cold gas chromatography vials (1 mL each) to evaluate whether inhibition of in vitro ethanol oxidation could be improved by altering sodium nitrite concentration. One milliliter of cold sodium nitrite ranging from ] to 75% (w/v) (saturated) was added immediately to one set of vials. Ethanol (21.71Jmol) was added to the second set of vials. Within 2 s, I mL of sodium nitrite over the same concentration range was added. Deproteinization ability was determined by the oxidation inhibition ratio. Results were compared using paired t-testing with an or value of less than 0.05 accepted as significant.
Sodium nitrite at every concentration significantly reduced the in vitro formation of acetaldehyde (Table II , p < 0.05, all comparisons with blank). However, 60 and 75% (saturated) sodium nitrite were better than the lower concentrations (1-40%) (Table II, p < 0.05, all comparisons).
Effect of saturated sodium nitrite volume.
To evaluate the possibility that increasing the volume of saturated sodium nitrite would improve oxidation inhibition, blood from a single individual (10 mL), was aliquoted into ten ice-cold gas chromatography vials (1 mL each). Five vials served as blanks. To the other five vials, 21.71Jmol ethanol was added. Saturated sodium nitrite was added to both the blank and ethanol vials. The volume of saturated sodium nitrite was either 1, 2, 3, 4, or 5 mL. The ability to inhibit ethanol oxidation was expressed as the oxidation ratio. With increasing volumes of sodium nitrite, the oxidation inhibition ratio increased sequentially from 1.43 to only 1.85, suggesting that increasing the volume of sodium nitrite offered no significant improvement in oxidation inhibition.
Confirmation of inhibition without suppression of recovery
A second series of experiments was performed to evaluate the effectiveness of sodium nitrite as an inhibitor of in vitro oxidation. Blood (6 mL) was drawn from ten individuals with ice-cold syringes. For each individual, the sample was split into two sets of three 1-mL vials. In each set, one vial without additives was considered a blank. the acetaldehyde areas in blood containing 22.7 IJmol/L acetaldehyde with and without nitrite were compared in order to verify a lack of suppression of sodium nitrite on acetaldehyde recovery. All comparisons used Student's paired t-test with an (x value less than 0.05 accepted as significant.
Sodium nitrite significantly reduced the acetaldehyde peak area in blood containing 21.7 mmol/L ethanol (Figure 2 , right bars, p < 0.001) such that the acetaldehyde peak area in the presence of sodium nitrite was not different from the acetaldehyde observed in blank blood (Figure 2, left and fight bars) . In contrast, the addition of sodium nitrite had no impact on the acetaldehyde peak area in blank blood (Figure 2, left bars) or in blood containing 22.7 lJmol/L of acetaldehyde (Figure 2, center bars) .
Standard curves
Assay linearity and intersubject variation in the in vitro formation of acetaldehyde were evaluated by performing standard curves for ethanol and acetaldehyde in blood drawn from seven individuals. Fresh whole blood was drawn into ice-cold syringes and placed into ice-cold GC vials. Vials were prepared one at a time. The internal standard and ethanol standard (0-50 IJL) were added to one set of vials to yield final ethanol concentrations of 0 to 32.5 mmol/L. The internal standard and acetaldehyde standard (0-50 I~L) were added to a second set of vials to yield acetaldehyde concentrations of 0 to 113.5 ]Jmol/L. For all vials, 1 mL of cold saturated sodium nitrite was added within 2 s of the addition of ethanol or acetaldehyde. All vials were immediately gas-tight sealed and stored at 4~ until assay, which was performed within 2 h.
The ethanol assay was linear (r 2 = 0.999, Figure 3A ) over the concentration range of 2.17 to 32.5 mmol/L. The concentration of acetaldehyde in blank blood was 1.13 _+ 0.9 I~mol/L, and the acetaldehyde assay was linear over the concentration range of 0.22 to 113.5 pmol/L ( Figure 3B ). The interassay coefficients of variation were 1.9 and 7.7% for ethanol and acetaldehyde, respectively, and the intra-assay coefficients of variation were 2.0 and 1.6% for ethanol and acetaldehyde, respectively.
In the presence of sodium nitrite with ethanol concentrations between 4.3 and 21.7 mmol/L, the spontaneous formation of acetaldehyde displayed intersubject variability with coefficients of variation between 31--46%. Within an individual, the in vitro formation of acetaldehyde was linearly related to ethanol concentration (r 2 > 0.99). In the individual with the largest amount of in vitro formation, the increase in acetaldehyde concentration at an ethanol concentration of 10.8 mmol/L was 3 IJmol/L.
Effect of storage
In order to evaluate the effect of storage, whole blood samples (1 mL each) were spiked with ethanol to final concentrations from 0.22 to 13.0 mmol/L (N = 5, each concentration). A second series of whole blood samples (1 mL each) were spiked with acetaldehyde to final concentrations from 0.22 to 113.5 lamol/L (N = 5, each concentration). The internal standard and I mL saturated sodium nitrate were added, and the samples were gas tight sealed. One ethanol and one acetaldehyde sample were analyzed immediately, the remainder were stored over liquid nitrogen at-195~ A storage temperature of-195~ was chosen rather than the commonly used --80~ based on the freezing point of acetaldehyde (-123.5~ and our experience with poor recovery of acetaldehyde when stored at-80~ Samples were thawed and assayed at 1, 2, 3, and 5 days. The amount of variance was described by coefficients of variation using the initial sample analysis as baseline. Coefficients of variation in excess of 10% were considered unacceptable.
Ethanol samples remained stable with storage at-195~ for 5 days with coefficients of variation between 0.3 and 8% ( Figure  4A ). In contrast, acetaldehyde was stable at -195~ for only 2 days. At 2 days, all the coefficients of variation for acetaldehyde measurement except one were between 5-10% ( Figure 4B ). When acetaldehyde assays were performed at either day 3 or day 5, significant decreases in the amount of acetaldehyde present were observed, and an increase in variation was noted with all coefficients of variation between 12 and 28%. 
Application of Method to In Vivo Human Studies
Healthy, nonpregnant women were recruited for ethanol and acetaldehyde metabolism studies. Following a 0.5 g/kg oral dose of ethanol, multiple 1-mL blood samples were drawn from an indwelling catheter for 8 h. Within 2 s of being drawn, the whole blood samples (1 mL) were added to cold GC vials containing I mL saturated sodium nitrite. The internal standard, 1-propanol, was added and the vials gas-tight sealed. Vials were stored at 4~ to be analyzed within 2 h. A subject-specific standard curve was prepared by the addition of the individual's blank blood to iced GC vials. The appropriate amount of ethanol or acetaldehyde stock solution and the internal standard (10-50 IJL) were added to each vial, and 1 mL of cold, saturated sodium nitrite was added immediately. Following incubation at 75~ for 16 rain, the headspace sample (3 mL vapors) was injected onto the Carbowax column, and concentrations were determined by flame ionization detection.
The ethanol and acetaldehyde areas under the concentration time curves were determined using the trapezoidal rule. The apparent ethanol Vmax and Km were determined by fitting the ethanol concentration time data using the MichaelisMenten equation and the computer software program Minsq (Micromath, Salt Lake City, UT). The acetaldehyde concentration time data were fit to an exponential equation using the M U I --- Journal of Analytical Toxicology, Vol. 21, March/April 1997 program Rstrip (Micromath), and the terminal exponent was used to determine the rate constant of dimination and its associated terminal half life. For both data sets, a model selection criteria greater than 3.0 and r 2 > 0.9 were the criteria for acceptable fit.
Six healthy African-American women (age range, 22-35 years) gave informed consent. Four women were smokers; two women were nonsmokers. In the two weeks before the study, three women consumed greater than seven drinks per week, two consumed 4-6 drinks per week, and one woman abstained. All women abstained from alcohol in the 12 h immediately before the study. Peak ethanol and acetaldehyde concentrations occurred within one half hour after ethanol ingestion (representative data, Figure 5 ). The median peak acetaldehyde concentration was 6.11JM (range, 2-80pM), whereas the median ethanol peak concentration was 17.7mM (range, 14-20mM). The areas under the concentration time curve for acetaldehyde and ethanol ranged from 3.8 to 13.4 pmol/Uh and from 32 to 80 mmol/L/h, respectively. The median terminal half life for acetaldehyde elimination was 46 rain (range, 7-105 rain). The apparent K m for ethanol was from 1.1 to 12.9pM; the apparent Vmax was from 38.4 to 114.7 pmol/h/kg.
Discussion
The decision regarding which method of ethanol and acetaldehyde determination should be chosen for a given analytical application must take into consideration what portion of total body acetaldehyde is measured, if simultaneous measurement of ethanol is desirable, and the accuracy of the sample processing and assay technique. Technical documentation should include adequate sensitivity and recovery, linearity over the 100000 t 90000 80000 anticipated concentration range, reproducibility, and adequate stability of the compounds measured over the time the assay is to be performed. For practical reasons, consideration must be given to the ease of use of the method in a given application. The method presented is an accurate, sensitive, automated technique for the simultaneous measurement of whole blood ethanol and acetaldehyde for in vivo human studies of ethanol metabolism as demonstrated in the subjects evaluated. Headspace injection eliminates the extensive sample preparation, which decreases technician time and helps reduce the loss of acetaldehyde from vaporization. Automation and short run times enhance convenience and efficiency. The assay is linear for both ethanol and acetaldehyde over the concentration ranges expected in human in vivo studies (16, 28) . The sensitivity achieved for acetaldehyde in this method required maximizing the sample on column using a large sample loop size, high carrier gas flow rates, low split ratios, and a large stationary phase (data not shown). Furthermore, high-purity helium (99.999%) minimized background noise.
The present method uses sodium nitrite as a deproteinizing agent. Sodium nitrite is a known oxygen scavenger that deproteinates and also decreases the oxidation of ethanol to acetaldehyde by conversion of oxyhemoglobin to methemoglobin (29) . Compared with sodium azide, which has also been advo- cated for the inhibition of ethanol oxidation (2, 5) , sodium nitrite was superior in inhibiting the in vitro oxidation of ethanol to acetaldehyde and was superior in the recovery of acetaldehyde. It is possible that the difference observed between nitrite and azide is secondary to the difference in concentrations used, and it is possible that using high concentrations of sodium azide might enhance the inhibition observed. We chose the concentration of azide based on previous published use (5) . Also, because azide is more dangerous than nitrite, we chose to limit our use to low concentrations. The most worrisome property of azide is its ability to release hydrazoic acid, which is highly volatile, toxic to humans, and highly explosive (30) . In a recent azide-induced explosion and fire, 11 workers suffered inhalational injuries that were sodium azide induced (31) . In addition, sodium azide is a potent mutagen (32) , and multiple cases of significant toxicity following relatively small accidental laboratory ingestions have been reported (32, 34) .
As an alternative to increasing azide concentration, we attempted to improve oxidation inhibition by combining azide, which inhibits by reducing hemoglobin to oxyhemoglobin, with polyethylene glycol, which deproteinates by exclusion (35) . The concentrations chosen were similar to those used by others (5) . Surprisingly, the combination of polyethylene glycol and azide led to a decrease in the inhibition of oxidation achieved with azide alone and, equally importantly, ted to a loss of recovery of acetaldehyde. Other authors have suggested that deproteinization by polyethylene glycol alone is only 80% effective (5); therefore, we did not evaluate it individually.
In addition to sodium nitrite and azide, the current analysis evaluated the two other sample processing methods previously reported: the use of zinc sulfate and barium hydroxide (36) , two salts that deproteinate by increasing ionic strength (37) , and perchloric acid, which deproteinates through pH alterations (37) . The use of perchloric acid, which achieves greater than 98% deproteinization (38) , is one of the most common methods of processing ethanol samples (19, 26, 28) . In our analysis, the perchloric acid method appeared as ineffective as saline in inhibiting the in vitro oxidation of ethanol, even when the perchloric acid was added within 2 s as suggested by Eriksson (26) . This lack of effectiveness is not likely secondary to inadequate deproteinization, but may reflect the activity of perchloric acid 
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as an oxidizing acid with its oxygen atoms available for contribution to spontaneous nonenzymatic oxidation. We also evaluated perchloric acid using a high concentration in combination with semicarbazide, a trapping reagent, that has been used primarily in plasma analyses to decrease the loss of acetaldehyde during centrifugation steps (2, 4, 39) . Although the recovery of acetaldehyde was acceptable using perchloric acid and semicarbazide, the in vitro oxidation of ethanol was the worst. This may be related to the high concentration of perchloric acid providing a large amount of oxygen for nonenzymatic oxidation, or it may be related to the delay in adding the deproteinizer, perchloric acid. The latter idea would suggest that methods using trapping or derivatizing steps may resu]t in spuriously high concentrations of acetaldehyde if deproteinization is not carried out simultaneously. Deproteinization methods not analyzed in the present study included the use of organic solvents, heat denaturation, precolumn stationary columns, and ultrafiltration. Organic solvents, which deproteinate by decreasing the dielectric constants, must be used in large amounts (an organic to sample ratio of 2:1) to achieve adequate deproteinization (37) . For gas chromatography using headspace analysis, this large volume of organic solvent may lead to interference with the peaks of ethanol and acetaldehyde. Heat denaturation requires prior derivatization to prevent loss from volatility, and, even with derivatization, it would enhance the spontaneous oxidation of alcohol to acetaldehyde (40) . Precolumn stationary columns and ultrafiltration techniques would also require prior derivatization to minimize vaporization loss.
The method presented is an accurate, sensitive, and practical method to measure ethanol and acetaldehyde simultaneously in whole blood. Although no method totally eliminates the in vitro formation of acetaldehyde from ethanol (41, 42) , the presented deproteinization method appears superior to previously reported methods while offering adequate sensitivity for human in vivo studies. Further, the convenience of the method suggests it is a more desirable approach for in vivo ethanol metabolic studies than HPLC methods that require labor intensive sample preparation and two separate assays for ethanol and acetaldehyde.
